ET vs Reactive Thrombocytosis: What's the Difference?

Essential thrombocythemia (ET) is a rare blood cancer—specifically a myeloproliferative neoplasm (MPN) (a slow-growing blood cancer where the bone marrow makes too many blood cells)—where the bone marrow independently overproduces platelets ^[1]. In contrast, reactive thrombocytosis (also called secondary thrombocytosis) means your platelet count is high because your body is responding to signals from another condition, such as a physical illness, iron deficiency, or inflammation ^[2][3].

What is the Difference?

ET is a “primary” or “clonal” condition. This means there is an acquired mutation (a genetic change that happens during your lifetime, not one you inherited) in the bone marrow stem cells, causing them to constantly make too many platelets even when the body doesn’t need them ^[1].

Reactive thrombocytosis means your bone marrow is receiving external signals to ramp up platelet production. It is not a cancer and is non-clonal. While brief emotional stress does not typically cause sustained high platelets, physical stress on the body can. Common triggers for reactive thrombocytosis include ^[2][3][4]:

• Acute or chronic infections
• Iron deficiency anemia or ongoing blood loss
• Inflammatory conditions (like rheumatoid arthritis or inflammatory bowel disease)
• Recent surgery, physical injury, or tissue damage
• Having your spleen removed (splenectomy) ^[5]
• Certain underlying cancers outside the bone marrow

Reactive thrombocytosis is often temporary, but it can persist as long as the underlying trigger—such as chronic inflammation, a hidden malignancy, or ongoing iron deficiency—remains unresolved ^[2][5].

How Doctors Make the Diagnosis

A high platelet count on a single blood test cannot distinguish between ET and reactive thrombocytosis ^[6]. Current medical guidelines generally define ET using a sustained platelet count of at least 450 × 10^9/L (450,000/µL) over time, alongside other specific criteria ^[1]. To figure out the cause, doctors use a step-by-step approach:

1. Checking for Reactive Causes

Your care team will review your complete blood count (CBC) history, examine a peripheral blood smear (looking at your blood cells under a microscope), and run targeted blood tests:

• Iron levels: Tests like ferritin (stored iron) and transferrin saturation (available iron) help evaluate iron deficiency ^[2][7]. If low iron is found, doctors will investigate the cause (such as blood loss) and treat it appropriately to see if your platelets normalize ^[2].
• Inflammatory markers: Tests like C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) can indicate active inflammation in the body ^[8]. They cannot pinpoint a specific hidden infection on their own, but they help doctors understand if a reactive process is likely ^[8].

2. Genetic Testing

If platelets remain elevated, doctors test your blood for acquired genetic mutations: JAK2, CALR, and MPL ^[9][10].

• A positive result: Finding one of these mutations strongly supports that a primary clonal process is happening ^[11]. However, it does not confirm ET all on its own, because these same mutations can occur in related MPNs like polycythemia vera or primary myelofibrosis ^[11][12].
• A negative result: Lacking these mutations does not completely rule out ET. Some patients have “triple-negative” ET, meaning they have the condition without these specific markers ^[13][14].

3. Bone Marrow Biopsy

A bone marrow biopsy helps establish the final diagnosis. It is a crucial step not just for patients without mutations, but for distinguishing ET from other disorders, especially prefibrotic primary myelofibrosis (a related bone marrow condition that can mimic ET but may progress differently) ^[14][12]. A pathologist examines the bone marrow’s physical structure and the megakaryocytes (the bone marrow cells that make platelets) to build a complete diagnostic picture alongside your lab results and clinical history ^[15].

Why the Distinction Matters

Accurately diagnosing ET is important because a clonal MPN carries an increased risk of blood clots and, in some cases, excessive bleeding ^[1]. Reactive thrombocytosis is generally managed by treating the underlying cause, and its associated risks depend heavily on that underlying illness rather than the platelets themselves.

When to Seek Urgent Care: Whether you have ET or reactive thrombocytosis, seek immediate medical attention if you experience signs of a blood clot or severe bleeding. These include sudden weakness or speech difficulty, chest pain, shortness of breath, a painful or swollen leg, sudden severe headache, vision changes, or uncontrolled unusual bleeding.